Indivior Pharmaceuticals Stock
Indivior Pharmaceuticals Inc
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- Joseph J. Ciaffoni
- Employees
- 833
- Market cap
- $4 B
- IPO
- 29/12/2014
Indivior Pharmaceuticals Inc operates as a holding company within the Healthcare sector, specifically focusing on the Drug Manufacturers - Specialty & Generic industry. The company is primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Indivior Pharmaceuticals stock: price history
1D
-3.5%
1W
-9.4%
1M
-5.5%
6M
-0.8%
YTD
-9.6%
1Y
+31.4%
2Y
+298.6%
5Y
+104.7%
10Y
+71.7%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~20% weaker price swings than usual
Ask the agents about Indivior Pharmaceuticals
Analyst assessment of Indivior Pharmaceuticals
PRICE TARGET LOW
US$43.00
CONSENSUS
US$48.00
MEDIAN
US$48.00
PRICE TARGET HIGH
US$53.00
0
STRONG BUY
4
BUY
0
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 05/08/2026
Indivior Pharmaceuticals stock metrics
P/E
11.43
P/B
-19.56
EV/EBITDA
9.92
RETURN ON EQUITY
-58.7%
NET MARGIN
35.6%
DEBT/EQUITY
-2.45
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
87.7%
FLOAT SHARES
109,461,200
AVG. DAILY VOLUME (30D)
2,337,007
Insider transactions (SEC)
Anderson Woodrow D
Anderson Woodrow D
Heidbreder Christian
Ciaffoni Joseph
Ciaffoni Joseph
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -3.5%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Indivior Pharmaceuticals stock
What does Indivior Pharmaceuticals do?
Indivior Pharmaceuticals Inc is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is Joseph J. Ciaffoni, the company employs around 833 people.
The IPO was on 29/12/2014; the stock trades on NASDAQ under the ticker INDV.
What do analysts say about Indivior Pharmaceuticals stock?
4 analysts rate the stock, the consensus is Buy (as of 05/08/2026).
The average price target is US$48.00, ranging from US$43.00 to US$53.00, with a median of US$48.00.
This is an external assessment, not a statement by Market Jury.
When does Indivior Pharmaceuticals report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly -20% stronger than usual.
Does Indivior Pharmaceuticals pay a dividend?
Yes. The last dividend was US$8.13 per share, ex-date 30/10/2026, paid on 06/11/2026.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to Indivior Pharmaceuticals?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences, Amphastar Pharmaceuticals and Aquestive Therapeutics.
How can I get Indivior Pharmaceuticals stock analyzed?
Clicking "Analyze stock" lets five strategies assess Indivior Pharmaceuticals against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.